Trial intelligence / Profile preview

Omega-3, Vitamin D, Zinc, and Simvastatin for Pediatric Sickle Cell Vaso-occlusive Crisis

NCT04301336Phase 3Completed

Sponsor
Beni Suef University
Start
Nov 2019
Primary completion
Nov 2020
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
2
01

Overview

A Phase 3 trial of omega-3 fatty acid, vitamin d, zinc, simvastatin in sickle cell disease (SCD), sponsored by Beni Suef University. Started Nov 2019; status: completed.

02

Drugs

omega-3 fatty acidvitamin dzincsimvastatin
03

Conditions

sickle cell disease (SCD)

Beyond the preview

Go deeper on NCT04301336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04301336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call